Recursion Pharmaceuticals, Inc. (BMV:RXRX)
Mexico
· Delayed Price · Currency is MXN 89.00
+5.01 (5.96%)
At close: Dec 4, 2025
Recursion Pharmaceuticals Revenue
Recursion Pharmaceuticals had revenue of $5.18M USD in the quarter ending September 30, 2025, a decrease of -80.16%. This brings the company's revenue in the last twelve months to $43.69M, down -32.98% year-over-year. In the year 2024, Recursion Pharmaceuticals had annual revenue of $58.84M with 32.00% growth.
Revenue (ttm)
$43.69M
Revenue Growth
-32.98%
P/S Ratio
55.74
Revenue / Employee
$54.61K
Employees
800
Market Cap
44.67B MXN
Revenue Chart
* This company reports financials in USD.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Wal-Mart de México | 1,002.47B |
| Grupo Financiero Banorte | 134.72B |
| Arca Continental | 250.90B |
| Industrias Peñoles | 142.01B |
| GMéxico Transportes | 64.06B |
| FIBRA Prologis | 13.58B |
| Promotora y Operadora de Infraestructura, S. A. B. de C. V. | 19.54B |
| Fibra UNO | 30.53B |